PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 21660445-3 2011 A proposal has been made that 5-HT2A receptor agonists exert their inhibitory effect on escape by activating GABAergic interneurons located in the dPAG. dpag 147-151 5-hydroxytryptamine receptor 2A Rattus norvegicus 30-36 21660445-8 2011 The inhibitory effect caused by DOI, RO 60-0175, and mCPP was also blocked by previous intra-dPAG injection of the preferential 5-HT2A receptor antagonist ketanserin. dpag 93-97 5-hydroxytryptamine receptor 2A Rattus norvegicus 128-134 21660445-10 2011 CONCLUSIONS: Stimulation of 5-HT2A but not 5-HT2C receptors in the dPAG causes a panicolytic-like effect that is mediated by facilitation of GABAergic neurotransmission. dpag 67-71 5-hydroxytryptamine receptor 2A Rattus norvegicus 28-34 20478359-4 2010 The results showed that intra-dPAG injection of WAY-100635 or ketanserin, 5-HT(1A) and 5-HT(2A/2C) receptor antagonists, respectively, counteracted the anti-escape effect caused by bilateral intra-LHb injection of kainic acid (60pmol/0.2microl). dpag 30-34 5-hydroxytryptamine receptor 2A Rattus norvegicus 87-94 15962186-11 2005 The present findings suggest that the 5-HT2A/2C receptor agonist has an inhibitory effect on maternal aggressive behavior when microinjected into the DPAG and no effect when microinjected into the MS. Ketanserin (1.0 microg/0.2 microl) decreased locomotion when microinjected into the DPAG and MS, but did not affect aggressive behavior. dpag 150-154 5-hydroxytryptamine receptor 2A Rattus norvegicus 38-44 15962186-11 2005 The present findings suggest that the 5-HT2A/2C receptor agonist has an inhibitory effect on maternal aggressive behavior when microinjected into the DPAG and no effect when microinjected into the MS. Ketanserin (1.0 microg/0.2 microl) decreased locomotion when microinjected into the DPAG and MS, but did not affect aggressive behavior. dpag 285-289 5-hydroxytryptamine receptor 2A Rattus norvegicus 38-44 15962186-12 2005 We interpret these findings as evidence for a specific role of 5-HT2A/2C receptors in the DPAG in the inhibition of female aggressive behavior, dissociated from those on motor activity. dpag 90-94 5-hydroxytryptamine receptor 2A Rattus norvegicus 63-69 15342106-5 2004 We presently evaluate the role of the 5-HT1A, 5-HT2A and 5-HT2C receptors of the DPAG in the modulation of inhibitory avoidance and escape responses of rats submitted to the elevated T-maze. dpag 81-85 5-hydroxytryptamine receptor 2A Rattus norvegicus 46-58 15342106-9 2004 Intra-DPAG injection of the 5-HT1A agonist 8-OH-DPAT and of DOI, a preferential 5-HT2A agonist, also inhibited escape, an effect antagonized by WAY-100635 and ketanserin, respectively. dpag 6-10 5-hydroxytryptamine receptor 2A Rattus norvegicus 80-86 11401004-11 2001 Microinjections of methysergide, a non-specific antagonist of 5-HT receptors, or ketanserin, an antagonist of 5-HT2A receptors, into the dPAG before testing significantly inhibited the antinociception without affecting any of the behavioral or autonomic conditioned responses. dpag 137-141 5-hydroxytryptamine receptor 2A Rattus norvegicus 110-116